{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:42:32Z","timestamp":1794271352855,"version":"4.9.0"},"reference-count":16,"publisher":"American Society of Hematology","issue":"4","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,8,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The effects of B-cell depletion with rituximab on regulatory T cells (Tregs) have not been determined. We investigated Tregs in patients receiving rituximab for chronic idiopathic thrombocytopenic purpura (ITP). The peripheral blood Tregs, identified as CD4+FOXP3+ T cells, were measured by flow cytometry prior to and after the immunotherapy. In addition, Tregs were analyzed for their usage of the T-cell receptor (TCR) \u03b2-variable (VB) region gene as well as their regulatory function as assessed by cell proliferation assays. Pretreatment data revealed a reduced number and a defective suppressive capacity of Tregs in ITP patients compared with control individuals. In addition, Tregs showed a polyclonal spectratype. Patients, particularly responders, showed restored numbers of Tregs as well as a restored regulatory function upon treatment with rituximab. These results indicate that patients with active ITP have a defective T regulatory cell compartment that can be modulated by a B cell\u2013targeted therapy.<\/jats:p>","DOI":"10.1182\/blood-2007-12-129262","type":"journal-article","created":{"date-parts":[[2008,3,29]],"date-time":"2008-03-29T08:27:30Z","timestamp":1206779250000},"page":"1147-1150","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":367,"title":["Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell\u2013depleting therapy with rituximab"],"prefix":"10.1182","volume":"112","author":[{"given":"Roberto","family":"Stasi","sequence":"first","affiliation":[{"name":"Department of Medical Sciences, Ospedale Regina Apostolorum, Albano Laziale, Rome, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nichola","family":"Cooper","sequence":"additional","affiliation":[{"name":"Molecular Immunology Unit, Institute of Child Health, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Del Poeta","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tor Vergata University Hospital, Rome, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Stipa","sequence":"additional","affiliation":[{"name":"Division of Hematology, Ospedale Sant' Eugenio, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Laura Evangelista","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Ospedale Regina Apostolorum, Albano Laziale, Rome, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Abruzzese","sequence":"additional","affiliation":[{"name":"Division of Hematology, Ospedale Sant' Eugenio, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Amadori","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tor Vergata University Hospital, Rome, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111720375050800_B1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1160\/TH07-08-0513","article-title":"Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management.","volume":"99","author":"Stasi","year":"2008","journal-title":"Thromb Haemost"},{"key":"2019111720375050800_B2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/tmrv.2003.50004","article-title":"Cellular immune mechanisms in autoimmune thrombocytopenic purpura: An update.","volume":"17","author":"Coopamah","year":"2003","journal-title":"Transfus Med Rev"},{"key":"2019111720375050800_B3","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1182\/blood-2007-02-068999","article-title":"Response to B-cell depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura.","volume":"110","author":"Stasi","year":"2007","journal-title":"Blood"},{"key":"2019111720375050800_B4","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3.","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"2019111720375050800_B5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.0105-2896.2006.00414.x","article-title":"Regulatory T cells in the periphery.","volume":"212","author":"Lohr","year":"2006","journal-title":"Immunol Rev"},{"key":"2019111720375050800_B6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.immuni.2006.08.003","article-title":"From vanilla to 28 flavors: multiple varieties of T regulatory cells.","volume":"25","author":"Shevach","year":"2006","journal-title":"Immunity"},{"key":"2019111720375050800_B7","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1365-2796.2007.01836.x","article-title":"Regulatory T cells in health and disease.","volume":"262","author":"Rouse","year":"2007","journal-title":"J Intern Med"},{"key":"2019111720375050800_B8","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/ncprheum0624","article-title":"CD4+CD25+FoxP3+ regulatory T cells in autoimmune diseases.","volume":"3","author":"Valencia","year":"2007","journal-title":"Nat Clin Pract Rheumatol"},{"key":"2019111720375050800_B9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1600-0609.2006.00780.x","article-title":"Abnormality of CD4(+)CD25(+) regulatory T cells in idiopathic thrombocytopenic purpura.","volume":"78","author":"Liu","year":"2007","journal-title":"Eur J Haematol"},{"key":"2019111720375050800_B10","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.thromres.2006.09.008","article-title":"Reduced Cd4+Cd25+ T cells in patients with idiopathic thrombocytopenic purpura.","volume":"120","author":"Sakakura","year":"2007","journal-title":"Thromb Res"},{"key":"2019111720375050800_B11","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1600-0609.2007.00917.x","article-title":"Circulating dendritic cells subsets and CD4+Foxp3+ regulatory T cells in adult patients with chronic ITP before and after treatment with high-dose dexamethasome.","volume":"79","author":"Ling","year":"2007","journal-title":"Eur J Haematol"},{"key":"2019111720375050800_B12","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1182\/blood.V88.6.2144.bloodjournal8862144","article-title":"Presence in peripheral blood of healthy individuals of autoreactive T cells to a membrane antigen present on bone marrow-derived cells.","volume":"88","author":"Filion","year":"1996","journal-title":"Blood"},{"key":"2019111720375050800_B13","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1172\/JCI4238","article-title":"Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody.","volume":"102","author":"Kuwana","year":"1998","journal-title":"J Clin Invest"},{"key":"2019111720375050800_B14","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1182\/blood.V87.10.4245.bloodjournal87104245","article-title":"Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T-cell reactivity.","volume":"87","author":"Semple","year":"1996","journal-title":"Blood"},{"key":"2019111720375050800_B15","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1046\/j.1365-2249.2003.02239.x","article-title":"T cell receptor VB repertoire diversity in patients with immune thrombocytopenia following splenectomy.","volume":"133","author":"Fogarty","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"2019111720375050800_B16","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/nm921","article-title":"T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura.","volume":"9","author":"Olsson","year":"2003","journal-title":"Nat Med"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/112\/4\/1147\/1456225\/zh801608001147.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/112\/4\/1147\/1456225\/zh801608001147.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T02:07:11Z","timestamp":1708740431000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/112\/4\/1147\/25245\/Analysis-of-regulatory-Tcell-changes-in-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,15]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,8,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2007-12-129262","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.720032181.793515389","asserted-by":"object"}]},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,15]]}}}